EUCTR2012-001989-15-DE进行中（未招募）不适用
A randomised, placebo controlled, double blind, cross-over, single center clinical Study to investigate the effect of heart rate reduction with ivabradine on endothelial function and vascular stiffness in patients with stable coronary heart disease.
niversität des Saarlandes0 个研究点开始时间: 2012年5月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Male and female patients
- •-Age > 18 years old
- •-Resting heart rate = 70 bpm
- •-Sinus rhythm
- •-Chronic stable angina pectoris
- •-Coronary heart disease detected by coronary angiography
- •-Written informed consent to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 35
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •-Acute coronary syndrome / myocardial infarction
- •-CAD treated best by surgical coronary bypass grafting
- •-Stroke / TIA
- •-Resting heart rate < 70/min
- •-Indwelling pacemaker, AICD, metallic implants
- •-Valvular heart disease with indication for surgical intervention
- •-Caridac rhythm other than sinus
- •-Uncontrolled arterial hypertension
- •-Preexisting medication with study drug
- •-Symptomatic PAD
- •-Known diabetes mellitus
- •-Pre-menopausal women
研究者
相似试验
进行中（未招募）
不适用
A study to determine the effectiveness of a new medicine (XEN-D0103) in patients who have an irregular and often fast heart beat (which comes and goes) and who are fitted with a pacemaker.MedDRA version: 16.1Level: LLTClassification code 10034039Term: Paroxysmal atrial fibrillationSystem Organ Class: 100000004849Paroxysmal atrial fibrillationEUCTR2013-004456-38-GBXention Limited
进行中（未招募）
1 期
A randomised, placebo controlled, double-blind, cross-over trial of the Polypill on risk factor reduction - Polypill Prevention Trial 1 (PPT01)Hypercholesterolaemia and HypertensionMedDRA version: N/A Level: LLT Classification code 10020603 Term: HypercholesterolaemiaMedDRA version: N/A Level: LLT Classification code 10020772 Term: HypertensionEUCTR2010-019874-34-GBQueen Mary University of London
进行中（未招募）
1 期
A randomised, double blind, placebo controlled, crossover trial of the adjuvant properties of imipramine for the overactive bladder. - RCT of adjuvant imipramine for the overactive bladderEUCTR2008-000893-19-GBWhittington NHS Trust40
进行中（未招募）
不适用
A randomised, double blind, placebo controlled, cross over study of the effects of Buprenorphine Hemiadipate Hydrochloride/Naloxone Hydrochloride Dihydrate intravenous challenges in opioid dependent subjects stabilisied on sublingual Buprenorphine Hydrochloride/Naloxone Hydrochloride Dihydrate (Suboxone)Maintenance/substitution agent for the treatment of opioid dependence.MedDRA version: 14.1Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-002229-23-GBRB Pharmaceuticals Inc.
已完成
不适用
A randomised, double blind, placebo controlled, crossover trial of the adjuvant properties of imipramine for the overactive bladderOveractive bladder symptomsUrological and Genital DiseasesISRCTN31004502The Whittington Hospital NHS Trust (UK)40